Faculty

Spencer Behr, MD
Assistant Professor
UCSF School of Medicine
San Francisco, CA

Rachel Berkovich, MD
Clinical Assistant Professor
Keck School of Medicine
Dept. Radiology
Children’s Hospital
Los Angeles, CA

Chris Jensen, MD
Chief DI/IR
PIC Teleradiology
SCPMG, South Bay

Adam Plotnik, MD
Assistant Professor- Radiology
Co-Director, UCLA IVC Filter Clinic
Division of Interventional Radiology
David Geffen School of Medicine - UCLA
Los Angeles, CA

Elan Rosenthal, MD
IR, IVC Regional Champ
SCPMG - LAMC

Frank G. Shellock, Ph.D., FACR, FISMRM, FACC, FACSM
Adjunct Clinical Professor of Radiology and Medicine
Keck School of Medicine, USC
Director for MRI Studies of Biomimetic MicroElectronic Systems
National Science Foundation, Engineering Research Center
University of Southern California
Los Angeles, CA

Max Wintermark, MD
Professor of Radiology/ Neuroimaging and Neurointervention
Stanford Medical Center
Stanford, CA

All who have control of content for this activity and their spouses/partners have disclosed that they have no relevant financial relationships with commercial interests, except:

• Spencer Behr: GE Healthcare – Grants/Research support
• Max Wintermark: GE Healthcare NFL – Advisory Board
• Diego Covarrubias: Spartan Micro Inc – Advisory Board

Symposium Co-Chairs:
Crispina Chong-Han, MD
SCPMG
Orange County, CA

Jennifer Y Hsu, MD
SCPMG
Los Angeles, CA

Symposium Planning Committee:
David R Alvarez, MD
SCPMG – Orange County

Christopher Aquino, MD
SCPMG – San Diego

Daryl M. Chen, MD
SCPMG – South Bay

Diego A. Covarrubias, MD
SCPMG - West Los Angeles

Emma Cotaya
Sr, Meeting Planner
Meetings and Events

Christina Earhart, MD
SCPMG – Baldwin Park

Raymond Hung, MD
SCPMG – Fontana

Jason K. Lee, MD
SCPMG – Woodland Hills

Melanie Moore
Consultant
Regional Physician Education

Merrick T. Schneider, MD
SCPMG -

Sreevathasan Sridhar, MD
SCPMG – Los Angeles

Huan N. Tran, MD
SCPMG - Riverside

Andrew S. Wu, MD
SCPMG – Downey

PLANNING COMMITTEE DISCLOSURE STATEMENT

The planning committee members and their partners have nothing to disclose regarding any relationship with a pharmaceutical or industrial concern which might pose a potential, apparent, or real conflict of interest with regard to the planning of this activity.